INBX
Inhibrx, Inc. Common Stock
INBX
INBX
Delisted
INBX was delisted on the 29th of May, 2024.
127 hedge funds and large institutions have $1.55B invested in Inhibrx, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 111 → 127 (+16)
21% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 42
Holders
127
Holding in Top 10
4
Calls
$46.8M
Puts
$1.34M
Top Buyers
1 | +$30.2M | |
2 | +$21.9M | |
3 | +$9.48M | |
4 |
Millennium Management
New York
|
+$8.69M |
5 |
Morgan Stanley
New York
|
+$8.02M |
Top Sellers
1 | -$20.3M | |
2 | -$19.4M | |
3 | -$12.1M | |
4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$7.96M |
5 |
Two Sigma Investments
New York
|
-$7.59M |